A fractional Head of CMC engagement for a biotech advancing a GLP-1 therapy via polymeric nanoparticle delivery. The role provides technical and strategic CMC leadership, working closely with an external CDMO toward GMP clinical batch readiness.
This fractional contract engagement supports a biotech client developing a GLP-1 therapy built on a polymeric nanoparticle delivery platform. The programme includes spray-dried powder formulations and relies on an external CDMO for manufacturing. The CMC leader will provide roughly 20 to 30 hours of oversight per month, supplying the technical judgement needed to advance from development through to GMP clinical batches.
The role spans formulation and process development for PLGA or comparable nanoparticle systems, spray-drying process strategy, technology transfer planning, analytical method oversight, and regulatory content for IND-enabling and clinical-stage submissions. The successful candidate will work independently, engage deeply with technical detail, and drive decisions and action items to completion alongside company leadership and the CDMO partner.
- Lead CMC strategy for polymeric nanoparticle and spray-dried powder development, focusing on decisions that support scale-up and clinical supply.
- Guide formulation and process development for PLGA or comparable nanoparticle systems, covering critical process parameters, encapsulation, stability, and performance attributes.
- Direct the technical strategy for spray-drying nanoparticle suspensions into suitable powder formulations, assessing moisture, redispersibility, and delivery performance.
- Partner with the external CDMO to plan and oversee technology transfer, process scale-up, troubleshooting, and GMP manufacturing readiness.
- Establish and review critical quality attributes, analytical methods, raw material controls, and phase-appropriate process controls for nanoparticle and powder products.
- Contribute CMC strategy and technical content to regulatory submissions, including IND-enabling and clinical-stage documentation.
- Advanced degree in pharmaceutical sciences, chemical engineering, materials science, chemistry, or a related discipline, or equivalent industry experience.
- At least 10 years of progressive pharmaceutical CMC or product development experience.
- Direct, in-depth experience developing polymeric nanoparticles, including PLGA or comparable polymer systems.
- Hands-on experience with spray drying for pharmaceutical formulations, ideally spray-drying nanoparticle suspensions into powder.
- Demonstrated track record of scaling processes and transferring them to external manufacturing partners, with a clear understanding of the path to GMP and clinical trial batches.
- Ability to work independently in a fractional capacity, make clear technical recommendations, and move work forward with external partners.
Trusted by fast-growing companies around the world




